Beth C. Natt, MD, MPH, MBA a career pediatric hospitalist, was named the new System Medical Director of the Pediatric Service Line for Atlantic Health System and Chairperson of the Department of Pediatrics at Morristown and Overlook Medical Centers.
As people prepare to thrill at the phenomenon of the eclipse today, Lauren Lusardi, OD, FAAO, an optometrist with Atlantic Health System in New Jersey, breaks down how the event makes us susceptible to eye damage and useful tips on how to protect yourself.
NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T) cells in the treatment of the autoimmune disease lupus.
The EmPATH unit at Overlook Medical Center will put adult behavioral emergency patients into a setting in which they will get the appropriate care more quickly, thereby lessening volumes and wait times in the emergency department, and, ultimately, reducing the need for inpatient hospitalization.
Overlook Medical Center in NJ, is the 1st site in the nation to dose a patient in the Phase IIb RESTORE Trial for newly-diagnosed glioblastoma tumors. Researchers will see whether using NanO2 TM, a drug by NuvOx Pharma to infuse oxygen into hypoxic tissues, can boost traditional radiation and chemo.
Atlantic Health System honored a New Jersey State Trooper and members of the Montville Township First Aid Squad on Tuesday, May 23, 2023, as the first responders reunited with the man whose life they saved a year earlier when he suffered a stroke while driving along a busy highway.
Persona IQ features implantable sensor technology that records and wirelessly transmits gait data from the knee implant to a patient’s personal base station at home. The data is then securely delivered to a cloud-based platform accessible by the patient and their surgeon.
Atlantic Health System’s BioBank partners with National Cancer Institute’s Cooperative Human Tissue Network – Southern Division, to advance the science of medical research.
The BD Diabetes Center at Atlantic Health System’s Goryeb Children’s Hospital and diabetes research and advocacy organization JDRF, partnered to distribute a video series focusing on helping teens and young adults overcome the emotional challenges associated with newly diagnosed type 1 diabetes.
The BD Diabetes Center at Atlantic Health System’s Goryeb Children’s Hospital and diabetes research and advocacy organization JDRF, partnered to distribute a video series focusing on helping teens and young adults overcome the emotional challenges associated with newly diagnosed type 1 diabetes.
An implantable device that stimulates the vagus nerve, paired with traditional rehabilitation therapy, is being used to restore hand and arm function in stroke survivors treated in New Jersey.
Hospital joins only 160 other Centers of Excellence throughout the nation, designated as health care facilities that focus on multidisciplinary treatment of pancreas disease, treating the “whole patient” with a focus on the best possible outcomes and improved quality of life.
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program reached a significant milestone of performing over 4,000 transcatheter aortic valve replacement (TAVR) procedures with well over 650 in 2022 alone.
With more and more conversations about war swirling around us all, having honest, age-appropriate explanations can be the key to reassuring children, says Dr. Christopher Lynch.
Experts at Overlook are hoping that SurVaxM, a first-of-its-kind vaccine targeting a protein found in glioblastomas and other cancers, will give patients a better shot at long-term survival and improved function.
.jpg&width=400&height=400)
To help improve the patient experience while offering enhanced online safety, Atlantic Health System, a nationally recognized leader in innovative and high-quality health care, has partnered with Vouched, a leading developer of artificial intelligence and computer vision for real-time identity verification.
The American Cancer Society (ACS) has announced an $80,000 partnership with Atlantic Health System Cancer Care to help encourage more New Jersey women to get screening mammograms, as part of the national Return to Screening (RTS) initiative. Atlantic Health System is part of an overarching cohort with more than 51 institutions across the country to drive quality improvement processes and interventions in order to deliver cancer screenings appropriately, safely, and equitably during the COVID-19 pandemic and beyond. Atlantic Health System is the only New Jersey health system chosen to participate in the initial RTS cohort. The $80,000 grant will be divided among four Atlantic Health System sites.
This study may change the way we manage patients with moderate aortic stenosis and save lives.
Atlantic Health System’s Morristown Medical Center is the only hospital in New Jersey to offer AlignRT® heart-protecting and tattoo-free breast radiation treatment. The new technology protects the heart when radiating the left breast and eliminates the need for permanent tattoos that help guide the radiation therapist in positioning a patient for treatment.
Atlantic Health System has announced the launch of the Atlantic Health Cardiovascular Rescue and Recovery Program at Morristown Medical Center. Under the leadership of Drs. Dimitrios Karmpaliotis and Amirali Masoumi, the Cardiovascular Rescue and Recovery Program will provide advanced treatment for patients in need of complex percutaneous coronary intervention (PCI) due to severe, total or multiple difficult-to-treat blockages of their coronary arteries (PCI is angioplasty with or without a stent).
Atlantic Health System’s Morristown Medical Center, one of the nation’s leading heart hospitals, will host a virtual conference featuring some of the world’s most distinguished cardiovascular faculty, who will discuss the latest developments in heart disease. This program is cosponsored by the NJ Chapter of the American College of Cardiology.
Atlantic Health System’s Morristown Medical Center fellowship-trained scoliosis surgeon Jason E. Lowenstein, MD, leads the only surgical team in New Jersey to use a new, FDA-approved tethering system for minimally invasive scoliosis surgery that provides for flexible spinal deformity correction and faster healing. The team is also the first in the nation to use a new type of portable CT scanner to guide the procedure and actually “see” inside the spinal canal during the surgery using Stryker’s SpineMap 3D in conjunction with the tether.
Atlantic Health System’s Morristown Medical Center and Overlook Medical Center recently began pioneering the field of “mixed reality” technology to enhance outcomes in shoulder, hand and upper extremity surgeries. Mixed reality technology provides a virtual hologram that is projected adjacent to the patient during surgery, enabling the surgeon to synthesize online preoperative planning software with real time data analysis during shoulder replacement surgery. This groundbreaking technology enhances the highest level of precision and may in some cases shorten the length of surgery.
Two of the leading names in health care in the tri-state region, New Jersey–based Atlantic Health System and New York–based NYU Langone Health, are teaming up to give patients greater access to heart and liver transplants and the coordinated, high-quality care needed to stay healthy. The clinical affiliation will partner NYU Langone’s nationally recognized transplant program with the nationally ranked Atlantic Health System Heart Care program located at Morristown Medical Center’s Gagnon Cardiovascular Institute (Morristown, NJ) and the ground-breaking liver services at Overlook Medical Center (Summit, NJ).
Atlantic Health System Cancer Care will continue its tradition of world-class medical education by hosting its 2021 Annual Review in Oncology Virtual Symposium. The symposium, held via Microsoft Teams with free registration, will take place Saturday, June 26, 2021, from 8 a.m. to 12:30 p.m. ET. Distinguished faculty from some of the nation’s leading cancer centers will summarize the latest advances in six areas of oncology, as presented at the just-completed ASCO conference—the world’s premier meeting for cancer care professionals and researchers.
Atlantic Health System Cancer Care physicians are lead or co-authors of seven original studies to be presented and published at the 2021 ASCO Annual Meeting, held virtually June 4-8. The ASCO annual meeting is the world’s leading venue for presenting original clinical research on cancer.
New treatment could help people with phenylketonuria (PKU), a genetic disorder that prevents people from metabolizing phenylalanine. Newborns are tested for PKU, which, if not diagnosed early, can have devastating effects. Patients with PKU follow a specific diet for most of their lives.
Atlantic Health System has announced that Abhishek Singh, MD, PhD, has been named Medical Director of Atlantic Health System’s Heart Success program, which cares for patients with advanced heart failure. Dr. Singh is triple board-certified in internal medicine, cardiology, and advanced heart failure and transplant cardiology.
27-year-old Joe Slota suffered a hemorrhagic stroke caused by an arteriovenous malformation (AVM). Strengthened by the love of his family and friends throughout the ordeal, Slota co-authored a book on his experience, "Can't? Just Did!"
Atlantic Health System’s Morristown Medical Center has received American College of Cardiology (ACC) Transcatheter Valve Certification, a designation of excellence that recognizes demonstrated expertise and commitment in treating patients undergoing transcatheter valve repair and replacement procedures, including transcatheter aortic valve replacement (TAVR).
Fewer than half (48%) of patients receiving a heart stent, or percutaneous coronary intervention (PCI), had the provided stent card with them when surveyed at a later date, according to researchers at Atlantic Health System’s Morristown Medical Center. Even when they had their stent cards, most patients were unable to identify the type of stent they had, which blood vessel it was in, or the date of the previous procedure. Eighty-eight percent of patients did have their smartphone, however. The study will be presented as a moderated poster the morning of May 15, during the American College of Cardiology 70th Annual Scientific Session (ACC.21).
Atlantic Health System Cancer Care, in partnership with OncLive, invites health care professionals and others interested in the surgical management of melanoma to a virtual lecture by internationally known melanoma expert Charles M. Balch, MD, FACS, FASCO. Dr. Balch is this year’s Joseph Calello Melanoma Scholar. The free lecture and Q & A will be held on May 6, 11 a.m. – 12 p.m. ET.
Atlantic Health System Cancer Care physicians are co-authors of five original studies presented at this year’s AACR Annual Meeting, held virtually April 10-15 and May 17-21. The AACR meeting is one of the world’s premier scientific gatherings of cancer specialists and researchers.
Atlantic Health System is among the first hospitals in the region to be able to rapidly screen for key viral variants, a key advance for public health amid the pandemic.
Atlantic Health System has announced the opening of the Atlantic Aortic Center at Morristown Medical Center, under the direction of cardiac surgeon Benjamin Stephen van Boxtel, MD. U.S. News & World Report ranks Morristown Medical Center as “#1 in New Jersey” and a top 40 program nationally for Cardiology and Heart Surgery. Morristown Medical Center is also ranked as New Jersey’s best hospital.
With options for in-person PT limited by the pandemic, this New Jersey rehabilitation provider used an app to help patients find what they needed.
Dr. Cherry focused on results from a Juno Therapeutics phase 2 study of liso-cel, an investigational CAR T therapy being tested against aggressive relapsed/refractory B cell non-Hodgkin lymphoma. Early results indicate a good safety profile, with few adverse events reported. Dr. Cherry also presented on the final results of a phase 1 study of targeted therapy gilteritinib in newly diagnosed acute myeloid leukemia (AML). Gilteritinib targets the most common mutation that causes AML, the FLT3 gene. Gilteritinib is sold under the brand name Xospata® by Astellas Pharma.
For the second year, Philippe Géneréux, MD, Co-Director of the Structural Heart Program at Atlantic Health System’s Morristown Medical Center and an interventional cardiologist internationally known for his novel research, has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group. Dr. Géneréux is the only New Jersey-based physician-scientist to be named to this year’s list in the Clinical Medicine category. Clinical Medicine requires more highly cited papers than any other field to meet the criteria for inclusion on the Highly Cited list.
The study will explore pacritinib as a treatment for cytokine storm in hospitalized patients with severe COVID-19. Pacritinib is a new type of oral kinase inhibitor—a drug that blocks enzymes that may cause cancer cells to grow. As a multi-kinase inhibitor, pacritinib has the potential to prevent an inflammatory response that frequently leads to respiratory failure in severe COVID-19. The study will evaluate pacritinib in hospitalized patients with severe COVID-19 with or without cancer. Patients discharged from the hospital will complete their study treatment on an outpatient basis. The PRE-VENT study is sponsored by CTI BioPharma.
Atlantic Health System Cancer Care today announced that fellowship-trained medical oncologist, Shilpi Gupta, MD, has joined Morristown Medical Center’s comprehensive breast health program where her focus is breast oncology and research. Dr. Gupta is on staff at Atlantic Hematology Oncology at the hospital’s Carol G. Simon Cancer Center.
Atlantic Health System is enrolling women in a landmark study that uses a simple blood test for the CA-125 protein to screen women who are at low risk for ovarian cancer. The purpose of the clinical trial is to help determine whether this test can catch ovarian cancer early in women who would not normally be screened for it. Atlantic Health System hospitals are the only centers in the New York metro region to participate in the study, and have the third highest enrollment numbers in the nation.
Atlantic Health System has announced the opening of Morristown Medical Center’s new state-of-the-art, patient-centered Infusion Center located in the Carol G. Simon Cancer Center. The first of three phases of expansion of New Jersey’s pre-eminent cancer center, the new unit was funded in large part by donations made by community members in support of the Foundation for Morristown Medical Center’s Growing Forward Campaign.
September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.
This clinical trial increased an understanding of how T cells mount a response to COVID-19 infection. These findings pave the way for diagnostic tests that detect COVID immunity based on T cells instead of antibodies. Research demonstrates that generating neutralizing antibodies rather than T cells, may not be sufficient for long-term immunity. New discoveries suggest that vaccines will need to incorporate T cell targets to generate lasting COVID-19 immunity.
As we observe World Head and Neck Cancer Day 2020 (July 27), nationally known expert Tom Thomas, MD, MPH, has set out to clear up misunderstandings about how one type of head and neck cancer is related to human papillomavirus (HPV), which has historically been thought of primarily as a cause of cervical cancer. Dr. Thomas is medical director, Head and Neck Reconstructive Surgery and Transoral Robotic Surgery, Leonard B. Kahn Head and Neck Cancer Institute at Atlantic Health System’s Morristown Medical Center and Carol G. Simon Cancer Center. He is one of the leaders of the Atlantic HPV Center.
Atlantic Health System Cancer Care will continue its tradition of world-class medical education with its 2020 Annual Review in Oncology Virtual Symposium. The symposium, held virtually this year with free registration, will take place Saturday, June 27, 2020, from 8 a.m. to 12:30 p.m. ET. Distinguished faculty from some of the Northeast’s leading cancer centers will summarize the latest advances in oncology, which have recently been presented at international conferences. The diverse range of topics should be of interest to surgeons, medical and radiation oncologists and other physicians, nurses and allied health professionals.
The COVID Research Program is rapidly enrolling patients from New Jersey, which has one of the world’s highest concentrations of COVID-19 patients. Atlantic Health System offers a study sponsored by TScan Therapeutics, Inc., a leading T cell therapeutics company in Waltham, Massachusetts, focused on identifying the precise way the human immune system recognizes and responds to infections like COVID-19 or other diseases, like cancers. TScan has developed a novel technology that enables them to identify the natural targets of T cells.
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System. Early results appear promising in this phase 1/2 clinical trial of ADXS-503 being developed by Advaxis, Inc., a new type of cancer therapy which targets “hotspot” mutations that commonly occur in specific cancer types, both by itself and in combination with immunotherapy Keytruda® (pembrolizumab), which is commonly used to treat this type of lung cancer. Dr. Haigentz and colleagues published early results of this study in conjunction with ASCO 2020, the world’s premier scientific meeting for clinical research in oncology.
Dr. Alistar has pioneered the use of CPI-613® (devimistat), a unique first-in-class treatment for locally advanced or metastatic pancreatic cancer, in combination with two chemotherapy drugs. Devimistat uniquely targets enzymes involved in cancer cell metabolism, against pancreatic cancer. The study’s efficacy data suggest devimistat has synergy with chemotherapy.The current study was funded by the drug’s manufacturer, New Jersey-based Rafael Pharmaceuticals and by Atlantic Health System.
Atlantic Health System’s Morristown Medical Center, nationally recognized for heart care, today opened the second of two new 36-bed units for patients with heart disease, completing a two-story expansion of the Gagnon Cardiovascular Institute. The unit opened today will serve cardiac surgery patients, while the first 36-bed unit, which opened in November, serves structural heart disease patients who have complex disorders and diseases of the heart.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
